Showing results (1431-1440 of 1,514) with videos related to
Sort By:
Pageof 152
BMJ Global Health|March 6, 2020
Global health, global surgery and mass casualties: II. Mass casualty centre resources, equipment and implementationSergio Aguilera, Leonidas Quintana, Tariq Khan, et al.Biorxiv : the Preprint Server for Biology|April 2, 2024
The PRC2.1 Subcomplex Opposes G1 Progression through Regulation of CCND1 and CCND2Adam D Longhurst, Kyle Wang, Harsha Garadi Suresh, et al.Malaria Journal|October 23, 2022
Clinical characteristics of Plasmodium falciparum infection among symptomatic patients presenting to a major urban military hospital in CameroonDaniel Z Hodson, Yannick Mbarga Etoundi, Narcisse Mbatou Nghokeng, et al.Genome Research|July 1, 2011
Putting genetic interactions in context through a global modular decompositionJeremy Bellay, Gowtham Atluri, Tina L Sing, et al.Cold Spring Harbor Molecular Case Studies|May 6, 2016
Characterization of a novel fusion gene EML4-NTRK3 in a case of recurrent congenital fibrosarcomaSarah Tannenbaum-Dvir, Julia L Glade Bender, Alanna J Church, et al.Nature Communications|December 11, 2021
Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in EnglandGayatri Amirthalingam, Jamie Lopez Bernal, Nick J Andrews, et al.NPJ Systems Biology and Applications|January 28, 2022
High-throughput platform for yeast morphological profiling predicts the targets of bioactive compoundsShinsuke Ohnuki, Itsuki Ogawa, Kaori Itto-Nakama, et al.Elife|July 19, 2017
Histone H3G34R mutation causes replication stress, homologous recombination defects and genomic instability in S. pombeRajesh K Yadav, Carolyn M Jablonowski, Alfonso G Fernandez, et al.Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|December 18, 2025
Colorectal surgeons' perspectives and emotional responses to anastomotic leakage following rectal cancer resectionRuth Walsh, Caitlin Fanning, Paolo Meneghesso, et al.The Lancet. Infectious Diseases|May 9, 2026
Immunogenicity, reactogenicity, and safety of a reduced-interval 4CMenB primary immunisation schedule in UK infants: a multicentre, open-label, assessor-blinded, phase 4 randomised controlled trialNatasha Thorn, Zsofia Danos, Nick J Andrews, et al.Pageof 152